KingMed Diagnostics News and Activities

KingMed Diagnostics is a company listed under the stock ticker 603882 (CN).

View the org chart displaying its 12 main executives

Most searched biographies at KingMed Diagnostics

• Yaoming Liang, Chief Executive Officer
• Zhanwen Zeng, Director
• Xia Fan, Independent Director

Create your alert
to follow the executive moves at KingMed Diagnostics.

KingMed Diagnostics has 2,417 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Zymeworks has announced the acquisition of Theravance Biopharma  (posted on June 29 2026).
• Tissium has just announced a $68 Million fundraising (posted on June 29 2026).
• Oblenio Bio has just announced a $62 Million fundraising (posted on June 26 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Carl Gordon - Director at Odyssey Therapeutics
• Jan Van de Winkel - President and Chief Executive Officer at Genmab

Learn more about the Biotechnology industry

Press releases by KingMed Diagnostics

Social media about KingMed Diagnostics

• KingMed Diagnostics on Wikipedia, Google News & Yahoo Finance
• KingMed Diagnostics on LinkedIn, X (Twitter) & YouTube